Sana Biotechnology Inc expected to post a loss of 51  cents a share - Earnings Preview

Sana Biotechnology

29/07/2022 14:08

* Sana Biotechnology Inc  SANA.OQ   SANA.O  is expected
to show no
change in quarterly revenue when it reports  results on August 2
(estimated). 
    * ​Refinitiv's mean analyst estimate for Sana Biotechnology
Inc is
for a loss of 51 cents per share. For the same quarter last
year, the company reported a loss of 32 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $15​, above​ its last closing price
of $7.28. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.47       -0.47      -0.47     Met     0.7
 Dec. 31 2022              -0.55      -0.60     Missed  -8.1
 Sep. 30 2021  -0.46       -0.49      -0.46     Beat    6.8​
 Jun. 30 2021  -0.44       -0.45      -0.32     Beat    28.9
 ​​Mar.        -0.57       -0.58      -0.45     Beat    22.4
 31 2021                                                
 Dec. 31 2020  -0.41       -0.41      -2.98     Missed  -626.8
                                                        ​
 This summary was machine generated July 29 at 13:08 GMT.  All
figures in US dollars  unless otherwise stated